Zika Virus Testing Market Share, Trends | Report 2032-2032

Zika Virus Testing Market Size - By Test Type (Serological tests, Molecular Tests), By End User (Hospitals, Diagnostic Centers, Clinics, Public Health Laboratory) – Global Forecast to 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Zika virus testing industry 3600 synopsis, 2018 - 2032 (USD Million)

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Test type trends

2.5&nbsp;&nbsp;&nbsp; End user trends

Chapter 3&nbsp;&nbsp;&nbsp;Zika Virus Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing prevalence of zika virus infection

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing R&amp;D by biopharmaceutical companies

3.2.1.3&nbsp;&nbsp;&nbsp;Technological advancements

3.2.1.4&nbsp;&nbsp;&nbsp;Government initiatives to generate awareness regarding zika virus

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Excessive cost of testing Kits

3.2.2.2&nbsp;&nbsp;&nbsp;Lack of reimbursement scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By test type

3.3.2&nbsp;&nbsp;&nbsp; By end user

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.4&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.7&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Zika Virus Testing Market Size and Forecast, By Test Type (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by test type

5.2&nbsp;&nbsp;&nbsp; Serological Tests

5.2.1&nbsp;&nbsp;&nbsp; Enzyme-linked immune sorbent assay (ELISA)

5.2.2&nbsp;&nbsp;&nbsp; Plaque reduction and neutralization test (PRNT)

5.3&nbsp;&nbsp;&nbsp; Molecular Tests

5.3.1&nbsp;&nbsp;&nbsp; Reverse transcription polymerase chain reaction (RT-PCR)

5.3.2&nbsp;&nbsp;&nbsp; Nucleic acid amplification testing (NAAT)

Chapter 6&nbsp;&nbsp;&nbsp;Zika Virus Testing Market Size and Forecast, By End User (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by end user

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.3&nbsp;&nbsp;&nbsp; Diagnostic centers

6.4&nbsp;&nbsp;&nbsp; Public health laboratory

6.5&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Zika Virus Testing Market Size and Forecast, By Region (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.3.6&nbsp;&nbsp;&nbsp; Belgium

7.3.7&nbsp;&nbsp;&nbsp; The Netherlands

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; Thailand

7.4.7&nbsp;&nbsp;&nbsp; Singapore

7.4.8&nbsp;&nbsp;&nbsp; Vietnam

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Colombia

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Turkey

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.2&nbsp;&nbsp;&nbsp; Altona Diagnostics GmbH

8.3&nbsp;&nbsp;&nbsp; ChemBio Diagnostics, Inc.

8.4&nbsp;&nbsp;&nbsp; ELITechGroup

8.5&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

8.6&nbsp;&nbsp;&nbsp; Genekam

8.7&nbsp;&nbsp;&nbsp; DiaSorin (Luminex Corporation)

8.8&nbsp;&nbsp;&nbsp; Novacyt Group

8.9&nbsp;&nbsp;&nbsp; Quest Diagnostics

8.10&nbsp;&nbsp;&nbsp; Siemens Healthcare GmbH

8.11&nbsp;&nbsp;&nbsp; LGC Limited (SeraCare Life Sciences)

8.12&nbsp;&nbsp;&nbsp; Co-Diagnostics, Inc.

8.13&nbsp;&nbsp;&nbsp; Mediven (Medical Innovation Ventures )

8.14&nbsp;&nbsp;&nbsp; Biocan Diagnostics, Inc.

8.15&nbsp;&nbsp;&nbsp; Euroimmun

&nbsp;&nbsp;&nbsp;

Zika Virus Testing Market

Get a free sample of this report